Tau Finanziaria Spa Sigma is 10% at SCICLONE PHARMACEUTICALS INC (SCLN). They have made 13 open-market trades across 5 companies since 2006, most recently 2012-04-30.
CIK 0001092601
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
11 open-market purchases totalling $25.3M since 2006, against 2 sales. Across 6 scored buys the stock is down 6.6% at ninety days, and 6.8 points behind the S&P over the same stretch.
6 scored purchases · one row per filing · discretionary only
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 0% | 0% | 0% |
| Avg Move | -15.2% | -6.6% | -6.6% |
| Alpha | -12.4% | -6.8% | -6.8% |
| Scored | 6 | 6 | 6 |
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| SCLN | SELL | 2012-04-30 | 2012-05-02 | $5.25 | $33.2M | -15.6% | -3.7% | -3.7% |
| SNGX | BUY | 2010-06-18 | 2010-06-21 | $0.21 | $1.8M | -12.8% | -21.0% | -21.0% |
| DORB | BUY | 2009-02-11 | 2009-02-13 | $0.18 | $4.5M | N/A | N/A | N/A |
| SCLN | BUY | 2008-01-30 | 2008-02-01 | $2.05 | $59K | -15.6% | -3.7% | -3.7% |
| SCLN | BUY | 2008-01-11 | 2008-01-15 | $2.00 | $57K | -15.6% | -3.7% | -3.7% |
| SCLN | BUY | 2007-11-13 | 2007-11-15 | $2.04 | $111K | -15.6% | -3.7% | -3.7% |
| SCLN | BUY | 2007-10-17 | 2007-10-19 | $2.05 | $85K | -15.6% | -3.7% | -3.7% |
| SCLN | BUY | 2007-10-01 | 2007-10-03 | $1.95 | $47K | -15.6% | -3.7% | -3.7% |
| RGN | BUY | 2006-12-21 | 2006-12-22 | $1.80 | $1.5M | N/A | N/A | N/A |
| QSC | SELL | 2006-12-20 | 2006-12-22 | $1.50 | $14.1M | N/A | N/A | N/A |
| QSC | BUY | 2006-12-20 | 2006-12-22 | $1.50 | $14.1M | N/A | N/A | N/A |
| QSC | BUY | 2006-12-13 | 2006-12-15 | $1.45 | $1.0M | N/A | N/A | N/A |
| RGN | BUY | 2006-03-06 | 2006-03-08 | $2.81 | $2.1M | N/A | N/A | N/A |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.